Symbols
Symbols
Aime
Products
News
Markets
Watchlist
Brokers
US Stocks
/
AKTX
/
revenue
A
AKTX
EPS
Revenue & Expenses
How did Akari Therapeutics' expenses impact its revenue in Q3 2024?
Ask Aime more questions
